semaglutide side effects headache Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain nausea and headache from semaglutide

64% of large firms say GLP-1 drug coverage moderately or significantly impacted their prescription drug spending Similar to the findings on use, 43% of firms with 1,000 to 4,999 workers, and 66% of firms with 5,000 or more workers, say that covering GLP-1 agonists for weight loss had a significant impact on the health plans prescription drug spending

Substantial methodological differences between studies complicate matters further, with some studies controlling for medication whereas others do not (Romano et al., 2021)

BCBS of Massachusetts member communications, 2025 New Hampshire Medicaid dropped GLP-1 obesity coverage effective January 1, 2026 affecting Harvard Pilgrim NH Medicaid enrollees

These symptoms warrant a conversation with your medical provider